8-KOther EventsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Corporate Update (Dec 23, 2009)

Filed December 23, 2009For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has entered into a civil settlement with the U.S. Department of Justice concerning an investigation into post-market surveys conducted by Guidant Corporation prior to Boston Scientific's acquisition of Guidant in 2006. This filing, an 8-K, serves to formally announce this settlement, which has been a known matter previously disclosed by the company. While the details of the settlement amount or specific terms are not provided in this particular 8-K filing, the resolution of this investigation is a significant development. Investors should note that this pertains to a historical issue inherited from the Guidant acquisition and represents a step towards closing this chapter. Further information regarding the settlement terms is expected to be available through the press release attached as an exhibit.

Key Highlights

  • 1Boston Scientific Corp. (BSX) has reached a civil settlement with the U.S. Department of Justice.
  • 2The settlement resolves an investigation into post-market surveys conducted by Guidant Corporation.
  • 3Guidant Corporation was acquired by Boston Scientific in 2006.
  • 4The investigation was previously disclosed by Boston Scientific.
  • 5The company has issued a press release dated December 23, 2009, detailing the event.
  • 6This filing confirms the resolution of a known legal matter.
  • 7The specific financial terms of the settlement are not disclosed in this 8-K filing.

Frequently Asked Questions

Boston Scientific Corporation has entered into a civil settlement with the U.S. Department of Justice to resolve an investigation into post-market surveys conducted by Guidant Corporation before the acquisition.

No, this investigation was a matter that Boston Scientific had previously disclosed. This 8-K filing serves to announce the civil settlement that resolves it.

The investigation pertained to certain post-market surveys conducted by Guidant Corporation when it was a separate entity, prior to its acquisition by Boston Scientific.

No, this specific 8-K filing does not disclose the financial terms or the exact amount of the civil settlement. Investors would need to refer to the press release attached as Exhibit 99.1 for potentially more details.